Ipsen: Berenberg starts monitoring with 'hold' rating

(CercleFinance.com) - Berenberg has started monitoring the pharma group Ipsen's shares on Wednesday with a "hold" rating and target price of 93 euros, as it begins to cover a number of European mid-caps, including the Belgian group UCB.


In its comments, the German broker believes that the fundamentals of the pharmaceutical sector are "healthy" and "sustainable".

Regarding European mid caps, analysts expect average annual sales growth of 6%, with earnings growth of 8% over the next five years, it says.

Berenberg has a buy recommendation on UCB and Lundbeck and a hold recommendation on Ipsen and Vifor.

At noon the Ipsen share is up about 0.5% at 90 euros.


Copyright (c) 2021 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.